Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 April 2019 | Story Rulanzen Martin | Photo Rulanzen Martin
SAGV Conference
From left; Dr Cilliers van den Berg, Head of the German Section; Prof Marianne Zappen-Thomson, President of SAGV and Dr Akila Ahouli, representative from GAS.

As much as it was a conference on Germanistik (German Studies) it also highlighted the international footprint of the University of the Free State (UFS) and the important role of international and national academic collaborations. 

The German Section in the Department Afrikaans and Dutch; German and French at the UFS hosted the second conference of the Association of German Studies in Southern Africa (SAGV) and German Studies in Sub-Saharan Africa (GAS) from 15-18 April 2019 on the UFS Bloemfontein Campus. 

“We are very proud to be hosting the conference. It is an international conference with delegates from overseas who are all working in German Studies or to use the German term Germanistik,” said Dr Cilliers van den Berg, Head of the German Section at the UFS. 

Waiting room in Germanistik explored

Warteräume (waiting rooms) was the theme of the four-day conference with various research papers on the role and/or value of these waiting rooms within Germanistik. “It is the transitional areas, within Germanistik, on every conceivable level,” said Van den Berg. The conference was sponsored by the embassies of Germany, Austria and Switzerland, as well as the German Academic Exchange Service and the Goethe Institute of Johannesburg.

“When I look at the theme of the conference it is extremely exciting because it reminds me of Homi Bhabha’s Third Spaces, liminal spaces and the in-betweeners,” said Prof Heidi Hudson, Dean of the Faculty of The Humanities. 

UFS and internationalisation


“One of the concepts we actively embrace is that of internationalisation. Globally and nationally, internationalisation has become accepted as one of the critical processes advancing the core business of universities,” said Prof Francis Petersen, Rector and Vice-Chancellor of the UFS.

The delegates who attended the conference were from countries which included, among others, Ethiopia, Burkina Faso, Italy, Kenya, Germany and Namibia as well as delegates from the universities of Stellenbosch, Pretoria, Rhodes and North-West. 

“You represent a multifaceted culture that has enriched our global academic and cultural landscape over many years: great minds like Goethe, Kafka, Beethoven, Mozart, Freud, and Einstein,” said Prof Petersen.


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept